Levitee Labs Inc
Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome,… Read more
Levitee Labs Inc (LVTTF) - Total Liabilities
Latest total liabilities as of June 2022: $6.47 Million USD
Based on the latest financial reports, Levitee Labs Inc (LVTTF) has total liabilities worth $6.47 Million USD as of June 2022.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Levitee Labs Inc - Total Liabilities Trend (2019–2021)
This chart illustrates how Levitee Labs Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Levitee Labs Inc Competitors by Total Liabilities
The table below lists competitors of Levitee Labs Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TERTIARY MINERALS
BE:TMU
|
Germany | €81.33K |
|
Univec Inc
PINK:UNVC
|
USA | $16.96 Million |
|
Spotlight Capital Holdings Inc
PINK:SLCH
|
USA | $648.37K |
|
SofTech Inc
PINK:SOFT
|
USA | $1.27 Million |
|
Octopus Titan VCT
LSE:OTV2
|
UK | GBX808.00K |
Liability Composition Analysis (2019–2021)
This chart breaks down Levitee Labs Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.45 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.07 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Levitee Labs Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Levitee Labs Inc (2019–2021)
The table below shows the annual total liabilities of Levitee Labs Inc from 2019 to 2021.
| Year | Total Liabilities | Change |
|---|---|---|
| 2021-09-30 | $4.30 Million | +167227.45% |
| 2020-09-30 | $2.57K | -82.75% |
| 2019-09-30 | $14.91K | -- |